Bingbing Lv
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: June 02, 2025
Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease.
Journal: Chemico-biological interactions
Published: May 23, 2025
Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: March 27, 2025
Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.
Journal: Bioorganic & medicinal chemistry
Published: March 12, 2025
Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance.
Journal: European journal of medicinal chemistry
Published: January 07, 2025
NRF2 inhibitors: Recent progress, future design and therapeutic potential.
Journal: European journal of medicinal chemistry
Published: August 05, 2024
Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
Journal: European journal of medicinal chemistry
Published: January 11, 2024
Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular plane.
Journal: European journal of medicinal chemistry
Published: January 09, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026